Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasileios Skouras

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Pulmonary Medicine|April 23, 2010
Chylothorax: diagnostic approachVasileios Skouras, Ioannis Kalomenidis
Breathe (Sheffield, England)|December 21, 2023
Medical treatment of pleural infection: antibiotic duration and corticosteroid usefulnessVasileios Skouras, Foteini Chatzivasiloglou, Marianthi Iliopoulou, et al.
European Journal of Internal Medicine|March 14, 2019
A six-year microbiologic study of hospital-acquired and health-care associated parapneumonic pleural infectionMarianthi Iliopoulou, Dionisios Spyratos, Ourania Kotsiou, et al.
Therapeutic Advances in Vaccines and Immunotherapy|February 28, 2025
Pembrolizumab-induced myasthenia gravis with isolated diaphragmatic involvement in a lung cancer patient: a case reportNefeli Mouratidou, Dimitrios Papadopoulos, Iro Vrouvaki, et al.
Cancers|March 28, 2024
Efficacy of NSCLC Rechallenge with Immune Checkpoint Inhibitors following Disease Progression or RelapseMaria Effrosyni Livanou, Vasiliki Nikolaidou, Vasileios Skouras, et al.
Respirology (Carlton, Vic.)|June 10, 2011
The efficacy of chest radiographs in detecting parapneumonic effusionsAnupama G Brixey, Yifeng Luo, Vasileios Skouras, et al.
Respirology (Carlton, Vic.)|October 15, 2011
Prognostic value of C-reactive protein in parapneumonic effusionsVasileios Skouras, Euaggelos Boultadakis, Dimitrios Nikoulis, et al.
Journal of Thoracic Disease|March 15, 2021
Bacteriology, antibiotic resistance and risk stratification of patients with culture-positive, community-acquired pleural infectionMarianthi Iliopoulou, Vasileios Skouras, Zoe Psaroudaki, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Pulmonary Medicine|April 23, 2010
Chylothorax: diagnostic approachVasileios Skouras, Ioannis Kalomenidis
Breathe (Sheffield, England)|December 21, 2023
Medical treatment of pleural infection: antibiotic duration and corticosteroid usefulnessVasileios Skouras, Foteini Chatzivasiloglou, Marianthi Iliopoulou, et al.
European Journal of Internal Medicine|March 14, 2019
A six-year microbiologic study of hospital-acquired and health-care associated parapneumonic pleural infectionMarianthi Iliopoulou, Dionisios Spyratos, Ourania Kotsiou, et al.
Therapeutic Advances in Vaccines and Immunotherapy|February 28, 2025
Pembrolizumab-induced myasthenia gravis with isolated diaphragmatic involvement in a lung cancer patient: a case reportNefeli Mouratidou, Dimitrios Papadopoulos, Iro Vrouvaki, et al.
Cancers|March 28, 2024
Efficacy of NSCLC Rechallenge with Immune Checkpoint Inhibitors following Disease Progression or RelapseMaria Effrosyni Livanou, Vasiliki Nikolaidou, Vasileios Skouras, et al.
Respirology (Carlton, Vic.)|June 10, 2011
The efficacy of chest radiographs in detecting parapneumonic effusionsAnupama G Brixey, Yifeng Luo, Vasileios Skouras, et al.
Respirology (Carlton, Vic.)|October 15, 2011
Prognostic value of C-reactive protein in parapneumonic effusionsVasileios Skouras, Euaggelos Boultadakis, Dimitrios Nikoulis, et al.
Journal of Thoracic Disease|March 15, 2021
Bacteriology, antibiotic resistance and risk stratification of patients with culture-positive, community-acquired pleural infectionMarianthi Iliopoulou, Vasileios Skouras, Zoe Psaroudaki, et al.
Pageof 1